866-997-4948(US-Canada Toll Free)

Cystic Fibrosis Global Clinical Trials Review, H2, 2014

Published By :

GlobalData

Published Date : Nov 2014

Category :

Clinical Trials

No. of Pages : 108 Pages


GlobalData's clinical trial report, Cystic Fibrosis Global Clinical Trials Review, H2, 2014" provides data on the Cystic Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cystic Fibrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cystic Fibrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Cystic Fibrosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cystic Fibrosis 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Cystic Fibrosis Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on Cystic Fibrosis 35
Nov 12, 2014: Arcturus Presents mRNA Delivery Data Applicable To CF Treatment 35
Oct 30, 2014: Phase 3 Clinical Trial in Cystic Fibrosis Begins 35
Oct 09, 2014: N8 Respiratory Presents Data Demonstrating Antimicrobial Efficacy of CSA-13 Against Psuedomonas Aeruginosa Biofilm 36
Sep 29, 2014: New data supports RPL554 as a potential novel cystic fibrosis therapy 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Vertex Pharmaceuticals Incorporated 38
Clinical Trial Overview of Vertex Pharmaceuticals Incorporated 38
Novartis AG 41
Clinical Trial Overview of Novartis AG 41
Gilead Sciences, Inc. 43
Clinical Trial Overview of Gilead Sciences, Inc. 43
Actavis plc 45
Clinical Trial Overview of Actavis plc 45
C. H. Boehringer Sohn AG & Co. KG 47
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 47
Merck & Co., Inc. 48
Clinical Trial Overview of Merck & Co., Inc. 48
PTC Therapeutics, Inc. 49
Clinical Trial Overview of PTC Therapeutics, Inc. 49
F. Hoffmann-La Roche Ltd. 50
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 50
Pharmaxis Limited 51
Clinical Trial Overview of Pharmaxis Limited 51
Abbott Laboratories 52
Clinical Trial Overview of Abbott Laboratories 52
Clinical Trial Overview of Top Institutes / Government 53
The Hospital for Sick Children 53
Clinical Trial Overview of The Hospital for Sick Children 53
The National Institute of Diabetes and Digestive and Kidney Diseases 54
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 54
National Center for Research Resources 55
Clinical Trial Overview of National Center for Research Resources 55
University of British Columbia 56
Clinical Trial Overview of University of British Columbia 56
University of Pittsburgh 57
Clinical Trial Overview of University of Pittsburgh 57
University of Alabama at Birmingham 58
Clinical Trial Overview of University of Alabama at Birmingham 58
Emory University 59
Clinical Trial Overview of Emory University 59
Imperial College London 60
Clinical Trial Overview of Imperial College London 60
University of North Carolina 61
Clinical Trial Overview of University of North Carolina 61
University of Texas Southwestern Medical Center at Dallas 62
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 62
Five Key Clinical Profiles 63

Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 108

List of Table


Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cystic Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Cystic Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Cystic Fibrosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Cystic Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Cystic Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Cystic Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2014* 15
Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cystic Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2014* 18
Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cystic Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cystic Fibrosis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Cystic Fibrosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Cystic Fibrosis Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Cystic Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 30
Cystic Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 31
Cystic Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 32
Cystic Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Cystic Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vertex Pharmaceuticals Incorporated, 2014* 38
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 41
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 43
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 45
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 47
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 48
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by PTC Therapeutics, Inc., 2014* 49
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 50
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmaxis Limited, 2014* 51
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 52
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014* 53
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 54
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 55
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 56
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 57
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 58
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 59
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 60
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of North Carolina, 2014* 61
Cystic Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 62

List of Chart


Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cystic Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Cystic Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Cystic Fibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Cystic Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Cystic Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Cystic Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2014* 15
Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cystic Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2014* 18
Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cystic Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cystic Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 30
Cystic Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 31
Cystic Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 32
Cystic Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Cystic Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 107

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *